Anticoagulant: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Subpagination Bot m (Add {{subpages}} and remove any categories (details)) |
||
| Line 1: | Line 1: | ||
{{subpages}} | |||
==Vitamin K antagonists== | ==Vitamin K antagonists== | ||
===Adverse effects=== | ===Adverse effects=== | ||
| Line 8: | Line 10: | ||
==See also== | ==See also== | ||
* [[Anticoagulation]] | * [[Anticoagulation]] | ||
Revision as of 16:58, 24 September 2007
Vitamin K antagonists
Adverse effects
Patients aged 80 years or more may be especially susceptible to bleeding complications with a rate of 13 bleeds per 100 person-years.[1]
References
- ↑ Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S (2007). "Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation". Circulation 115 (21): 2689-96. DOI:10.1161/CIRCULATIONAHA.106.653048. PMID 17515465. Research Blogging. PMID 17515465